Wednesday, May 31, 2023 | Back issues
Courthouse News Service Courthouse News Service


CHICAGO - Abbott, Solvay, GlaxoSmithKline and others pushed testosterone with false claims that it's a "cure for the male aging process," a pension fund claims in a RICO class action; click headline to see the defendants in Federal Court.

Here are the defendants: AbbVie, Abbott Laboratories, Abbott Products, Solvay America, Solvay Pharmaceuticals,; Solvay S.A., Unimed Pharmaceuticals, Besins Healthcare, Besins Healthcare SA, Auxilium Pharmaceuticals, GlaxoSmithKline, Oscient Pharmaceuticals, and Endo Pharmaceuticals. - allied services

Read the Top 8

Sign up for the Top 8, a roundup of the day's top stories delivered directly to your inbox Monday through Friday.